NASACORT

This brand name is authorized in Brazil, Canada, Estonia, Finland, France, Germany, Ireland, Malta, Mexico, Netherlands, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug NASACORT contains one active pharmaceutical ingredient (API):

1	Triamcinolone UNII F446C597KA - TRIAMCINOLONE ACETONIDE
	Triamcinolone acetonide is a more potent derivative of triamcinolone and is approximately 8 times more potent than prednisone. Although the precise mechanism of corticosteroid anti-allergic action is unknown, corticosteroids are very effective in the treatment of allergic diseases in man. Also, local injections are thought to have an anti-inflammatory effect.
	Read more about Triamcinolone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NASACORT Nasal Spray suspension	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R01AD11	Triamcinolone	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AD Corticosteroids
Discover more medicines within R01AD11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	576720090089117
CA	Health Products and Food Branch	02213834, 02417510
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00900525, 04439767, 08442192, 10811981
EE	Ravimiamet	1667752, 1667785
ES	Centro de información online de medicamentos de la AEMPS	61970
FI	Lääkealan turvallisuus- ja kehittämiskeskus	029494, 034900, 090662
FR	Base de données publique des médicaments	69649126
GB	Medicines & Healthcare Products Regulatory Agency	152496, 24756, 381542
IE	Health Products Regulatory Authority	34201, 34217, 34278
MT	Medicines Authority	MA1470/00801, MA1470/00901
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	287M97
NL	Z-Index G-Standaard	14215330
NL	Z-Index G-Standaard, PRK	50857
PL	Rejestru Produktów Leczniczych	100329642
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68039001, W68039002
SG	Health Sciences Authority	10821P
TN	Direction de la Pharmacie et du Médicament	7073011
TR	İlaç ve Tıbbi Cihaz Kurumu	8683060700015
ZA	Health Products Regulatory Authority	29/21.5.1/0715